The recent recognition of bisphosphonate use came into use for pathological conditions which includes osteonecrosis of the jaw (ONJ) and other bone diseases. This article highlights about bisphosphonate and its effect and affect on ONJ. Jaw necrosis is a complication associated with conditions such as radiotherapy, severe fungal or bacterial infections, and sarcoidosis or after intravenous bisphosphonate therapy. The intravenous bisphosphonates - pamidronate (Aredia) and zoledronic acid (Zometa), are often used to treat cancer-related hypercalcemia, Pagetís disease, symptoms from solid tumor bone metastasis and osteolytic lesions of multiple myeloma. Bisphosphonate related ONJ has been reported since 2003, in patients taking the drug, more often after dental procedures like extractions, minor surgeries, etc.
Bisphosphonates, Clinical practice, Mechanism, Osteonecrosis of jaw.
Percutaneous Sonographically Guided Release of Carpal Tunnel and Trigger Finger: Biomechanics, Clinical Results, Technical Developments.
Moungondo F, Feipel V
Hand clinics. 2022; 38(1): 91-100
Study on the antioxidative mechanism of tocopherol loaded ethyl cellulose particles in thermal-oxidized soybean oil.
Liu Y, Ma X, Li J, Fan L, Huang S
Carbohydrate polymers. 2022; 276(): 118734
Sonography, My Personal Assistant at Hand Outpatient Clinic.
Christen S, V√∂gelin E
Hand clinics. 2022; 38(1): 19-29
Culturing and Expansion of "Clinical Grade" Neural Stem Cells from the Fetal Human Central Nervous System.
Gelati M, Profico DC, Ferrari D, Vescovi AL
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 57-66
First, do no harm: impact of the transition to an integrated curriculum on medical knowledge acquisition of the transitional cohort.
Nackers K, Tatar R, Cowan E, Zakowski L, Stewart K, Ahrens S, Jacques L, Chheda S
Medical education online. 2022; 27(1): 2007561